NIGROSTRIATAL DAMAGE IS REQUIRED FOR INDUCTION OF DYSKINESIAS BY L-DOPA IN SQUIRREL-MONKEYS

被引:110
|
作者
BOYCE, S
RUPNIAK, NMJ
STEVENTON, MJ
IVERSEN, SD
机构
[1] Merck Sharp and Dohme, Research Laboratories, Neuroscience Research Centre, Harlow CM20 1QR, East Wick Road
关键词
dyskinesias; L-DOPA; Parkinson's disease; squirrel monkey;
D O I
10.1097/00002826-199010000-00006
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We examined the ability of L-DOPA to induce dyskinesias in MPTP-treated and normal squirrel monkeys to establish whether the underlying neuropathology associated with parkinsonism is an absolute requirement or merely promotes the development of drug-induced dyskinesias. Administration of L-DOPA (5-40 mg/kg p.o., following a 60 min pretreatment with carbidopa 2.5-20 mg/kg p.o.) induced a range of dopamine-mediated behaviours including locomotor activity, stereotyped scratching, and climbing in both lesioned and nonlesioned animals. However, the dose-response curves showed a marked (three- to fourfold) shift to the left if lesioned animals, indicating behavioural supersensitivity. In contrast, L-DOPA-induced dyskinesias were only observed in MPTP-treated monkeys. Doses required for induction of dyskinesias were lower than those required to induce climbing. These findings provide further evidence that nigrostriatal damage is essential for the genesis of L-DOPA-induced dykinesias.
引用
收藏
页码:448 / 458
页数:11
相关论文
共 50 条
  • [1] CHARACTERIZATION OF DYSKINESIAS INDUCED BY L-DOPA IN MPTP-TREATED SQUIRREL-MONKEYS
    BOYCE, S
    RUPNIAK, NMJ
    STEVENTON, MJ
    IVERSEN, SD
    PSYCHOPHARMACOLOGY, 1990, 102 (01) : 21 - 27
  • [2] L-dopa and dyskinesias in normal monkeys
    Pearce, RKB
    MOVEMENT DISORDERS, 1999, 14 : 9 - 12
  • [3] CCK-8S INHIBITS L-DOPA-INDUCED DYSKINESIAS IN PARKINSONIAN SQUIRREL-MONKEYS
    BOYCE, S
    RUPNIAK, NMJ
    STEVENTON, M
    IVERSEN, SD
    NEUROLOGY, 1990, 40 (04) : 717 - 718
  • [4] NB-355 - A NOVEL PRODRUG FOR L-DOPA WITH REDUCED RISK FOR PEAK-DOSE DYSKINESIAS IN MPTP-TREATED SQUIRREL-MONKEYS
    TYE, SJ
    RUPNIAK, NMJ
    NARUSE, T
    MIYAJI, M
    IVERSEN, SD
    CLINICAL NEUROPHARMACOLOGY, 1989, 12 (05) : 393 - 403
  • [5] MOLECULAR CHARACTERIZATION OF ACUTE DYSKINESIAS IN SQUIRREL-MONKEYS
    MAHY, N
    CUTILLAS, B
    FERRAN, A
    CAMPS, M
    CODINA, A
    MIQUEL, F
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 183 (02) : 167 - 167
  • [6] Increases in striatal preproenkephalin gene expression are associated with nigrostriatal damage but not L-DOPA-induced dyskinesias in the squirrel monkey
    Quik, M
    Police, S
    Langston, JW
    Di Monte, DA
    NEUROSCIENCE, 2002, 113 (01) : 213 - 220
  • [7] Safinamide reduces dyskinesias and prolongs L-DOPA antiparkinsonian effect in parkinsonian monkeys
    Gregoire, Laurent
    Jourdain, Vincent A.
    Townsend, Matthew
    Roach, Arthur
    Di Paolo, Therese
    PARKINSONISM & RELATED DISORDERS, 2013, 19 (05) : 508 - 514
  • [8] PARTIAL DAMAGE TO NIGROSTRIATAL BUNDLE - COMPENSATORY CHANGES AND THE ACTION OF L-DOPA
    ZIGMOND, MJ
    ABERCROMBIE, ED
    STRICKER, EM
    JOURNAL OF NEURAL TRANSMISSION-GENERAL SECTION, 1990, : 217 - 232
  • [9] L-Dopa induced dyskinesias in Parkinsonian mice: Disease severity or L-Dopa history
    Shan, Lufei
    Diaz, Oscar
    Zhang, Yajun
    Ladenheim, Bruce
    Cadet, Jean-Lud
    Chiang, Yung-Hsiao
    Olson, Lars
    Hoffer, Barry J.
    Baeckman, Cristina M.
    BRAIN RESEARCH, 2015, 1618 : 261 - 269
  • [10] Memantine improves L-dopa induced dyskinesias
    Varanese, S.
    Howard, J.
    Di Rocco, A.
    MOVEMENT DISORDERS, 2009, 24 : S360 - S360